Indications for renal denervation in the treatment of hypertension (2024)

References

Katsurada K, Shinohara K, Aoki J, Nanto S, Kario K. Renal denervation: basic and clinical evidence. Hypertens Res. 2022;45:198–209.
Article PubMed Google Scholar
Katsurada K, Ogoyama Y, Imai Y, Patel KP, Kario K. Renal denervation based on experimental rationale. Hypertens Res. 2021;44:1385–94.
Article CAS PubMed PubMed Central Google Scholar
Ogoyama Y, Abe M, Okamura K, Tada K, Katsurada K, Shibata S, et al. Effects of renal denervation on blood pressure in patients with hypertension: a latest systematic review and meta-analysis of randomized sham-controlled trials. Hypertens Res. 2024. https://doi.org/10.1038/s41440-024-01739-y. Online ahead of print.
Mancia G, Kreutz R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41:1874–2071.
Article CAS PubMed Google Scholar
Townsend RR, Mahfoud F, Kandzari DE, Kario K, Poco*ck S, Weber MA, et al. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet. 2017;390:2160–70.
Article PubMed Google Scholar
Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391:2335–45.
Article PubMed Google Scholar
Bohm, Kario M, Kandzari K, Mahfoud DE, Weber MA F, Schmieder RE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395:1444–51.
Article PubMed Google Scholar
Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, et al. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA. 2023;329:651–61.
Article PubMed PubMed Central Google Scholar
Pathak A, Rudolph UM, Saxena M, Zeller T, Muller-Ehmsen J, Lipsic E, et al. Alcohol-mediated renal denervation in patients with hypertension in the absence of antihypertensive medications. EuroIntervention. 2023;19:602–11.
Article PubMed Google Scholar
See Also
Mobile App Users Do Better Losing Weight GlobalRPH Dosing | PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)Renal Medicine | Oxford Assess and Progress: Clinical Medicine Weight Loss: Taking Action To See Results GlobalRPH
Lindenfeld J, Zile MR, Desai AS, Bhatt K, Ducharme A, Horstmanshof D, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial. Lancet. 2021;398:991–1001.
Article CAS PubMed Google Scholar
Ponikowski P, Kirwan BA, Anker SD, McDonagh T, Dorobantu M, Drozdz J, et al. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020;396:1895–904.
Article CAS PubMed Google Scholar
Bhatt AS, Moscone A, McElrath EE, Varshney AS, Claggett BL, Bhatt DL, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol. 2020;76:280–8.
Article CAS PubMed PubMed Central Google Scholar
Zile MR, Desai AS, Costanzo MR, Ducharme A, Maisel A, Mehra MR, et al. The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic. Eur Heart J. 2022;43:2603–18.
Article PubMed Google Scholar
Azzouzi S, Stratton C, Munoz-Velasco LP, Wang K, Fourtassi M, Hong BY, et al. The impact of the COVID-19 pandemic on healthy lifestyle behaviors and perceived mental and physical health of people living with non-communicable diseases: an international cross-sectional survey. Int J Environ Res Public Health. 2022;19:8023.
Bhatt AS, Kosiborod MN, Claggett BL, Miao ZM, Vaduganathan M, Lam CSP, et al. Impact of COVID-19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial. Eur J Heart Fail. 2023;25:2177–88.
Article CAS PubMed Google Scholar
Kandzari DE, Bohm M, Mahfoud F, Townsend RR, Weber MA, Poco*ck S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391:2346–55.
Article PubMed Google Scholar
Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397:2476–86.
Article CAS PubMed Google Scholar
Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. J Am Coll Cardiol. 2023;82:1809–23.
Article CAS PubMed Google Scholar
Vasquez Reyes M. The disproportional impact of COVID-19 on African Americans. Health Hum Rights. 2020;22:299–307.
PubMed PubMed Central Google Scholar
Bress AP, Cohen JB, Anstey DE, Conroy MB, Ferdinand KC, Fontil V, et al. Inequities in Hypertension Control in the United States Exposed and Exacerbated by COVID-19 and the Role of Home Blood Pressure and Virtual Health Care During and After the COVID-19 Pandemic. J Am Heart Assoc. 2021;10:e020997.
See Also
Dermatitis: A Comprehensive Prevalence And Quality Of Life Study GlobalRPH
Article CAS PubMed PubMed Central Google Scholar
Kario K, Yokoi Y, Okamura K, Fujihara M, Ogoyama Y, Yamamoto E, et al. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial. Hypertens Res. 2022;45:221–31.
Article PubMed Google Scholar
Kario K, Kai H, Nanto S, Yokoi H. Anti-hypertensive medication adherence in the REQUIRE trial: post-hoc exploratory evaluation. Hypertens Res. 2023;46:2044–7.
Article CAS PubMed PubMed Central Google Scholar
Kandzari DE, Weber MA, Pathak A, Zidar JP, Saxena M, David SW, et al. Effect of alcohol-mediated renal denervation on blood pressure in the presence of antihypertensive medications: primary results from the TARGET BP I randomized clinical trial. Circulation. 2024;149:1875–84.
Townsend RR, Walton A, Hettrick DA, Hickey GL, Weil J, Sharp ASP, et al. Review and meta-analysis of renal artery damage following percutaneous renal denervation with radiofrequency renal artery ablation. EuroIntervention. 2020;16:89–96.
Article PubMed Google Scholar
Mahfoud F, Bohm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the Global SYMPLICITY Registry. Eur Heart J. 2019;40:3474–82.
Article PubMed PubMed Central Google Scholar
Blood Pressure Lowering Treatment Trialists C. Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis. Lancet. 2021;397:1625–36.
Article Google Scholar
Narita K, Hoshide S, Kario K. Nighttime home blood pressure is associated with the cardiovascular disease events risk in treatment-resistant hypertension. Hypertension. 2022;79:e18–e20.
Article CAS PubMed Google Scholar
Kario K, Hoshide S, Mizuno H, Kabutoya T, Nishizawa M, Yoshida T, et al. Nighttime blood pressure phenotype and cardiovascular prognosis: practitioner-based nationwide JAMP study. Circulation. 2020;142:1810–20.
Article CAS PubMed PubMed Central Google Scholar
Kario K, Hoshide S, Narita K, Okawara Y, Kanegae H. Investigators n. cardiovascular prognosis in drug-resistant hypertension stratified by 24-hour ambulatory blood pressure: the JAMP study. Hypertension. 2021;78:1781–90.
Article CAS PubMed Google Scholar
Kario K, Saito I, Kushiro T, Teramukai S, Tomono Y, Okuda Y, et al. Morning home blood pressure is a strong predictor of coronary artery disease: the HONEST study. J Am Coll Cardiol. 2016;67:1519–27.
Article PubMed Google Scholar
Kario K. Time for focus on morning hypertension: pitfall of current antihypertensive medication. Am J Hypertens. 2005;18:149–51.
Article PubMed Google Scholar
Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder RE, et al. Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial. Hypertens Res. 2023;46:280–8.
Article CAS PubMed Google Scholar
Kario K, Weber MA, Mahfoud F, Kandzari DE, Schmieder RE, Kirtane AJ, et al. Changes in 24-hour patterns of blood pressure in hypertension following renal denervation therapy. Hypertension. 2019;74:244–9.
Article CAS PubMed Google Scholar
Gao JQ, Xu YL, Ye J, Hou SX, Yang W, Li M, et al. Effects of renal denervation on cardiac function after percutaneous coronary intervention in patients with acute myocardial infarction. Heliyon. 2023;9:e17591.
Article PubMed PubMed Central Google Scholar
Dai Q, Lu J, Wang B, Ma G. Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure. Int J Clin Exp Med. 2015;8:9779–85.
PubMed PubMed Central Google Scholar
Chen W, Ling Z, Xu Y, Liu Z, Su L, Du H, et al. Preliminary effects of renal denervation with saline irrigated catheter on cardiac systolic function in patients with heart failure: a Prospective, Randomized, Controlled, Pilot Study. Catheter Cardiovasc Inter. 2017;89:E153–E161.
Article Google Scholar
Gao JQ, Yang W, Liu ZJ. Percutaneous renal artery denervation in patients with chronic systolic heart failure: a randomized controlled trial. Cardiol J. 2019;26:503–10.
Article PubMed PubMed Central Google Scholar
Drozdz T, Jastrzebski M, Moskal P, Kusiak A, Bednarek A, Styczkiewicz K, et al. Renal denervation in patients with symptomatic chronic heart failure despite resynchronization therapy - a pilot study. Postepy Kardiol Interwencyjnej. 2019;15:240–6.
PubMed PubMed Central Google Scholar
Feyz L, Nannan Panday R, Henneman M, Verzijlbergen F, Constantinescu AA, van Dalen BM, et al. Endovascular renal sympathetic denervation to improve heart failure with reduced ejection fraction: the IMPROVE-HF-I study. Neth Heart J. 2022;30:149–59.
Article CAS PubMed Google Scholar
Pietila-Effati P, Hoglund M, Karajamaki A, Hoglund F, Nabb AM, Matila E, et al. Renal denervation in patients who do not respond to cardiac resynchronization therapy. Scand Cardiovasc J. 2022;56:103–6.
Article PubMed Google Scholar

Download references